The market reaction is overdone on Viking Therapeutics, says BTIG's Justin Zelin
CNBC Televisionยท2025-08-19 17:45
More on this. Our next guest today says today's reaction is overdone. That Vikings data is comparable or maybe even a bit better than Nova Nordisks and Eli Liys.He's sticking with a buy rating and a $125 price target. Joining me now is Justin Zelen. He's the biotech analyst at BTIG.All right, Justin, make your case. Why shouldn't investors abandon the stock as apparently so many of them are today. >> Thanks for having me on, David.Appreciate it. Yeah, I I I I have to say I think that the market reaction her ...